These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9477714)

  • 41. [Impact of various objectives related to the rational use of medication in a primary care area].
    Segade Buceta XM
    Aten Primaria; 2000 Mar; 25(4):236-41. PubMed ID: 10795437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Criteria for the development of a formulary of drugs in a basic health area and impact on prescription].
    Pérez Rodríguez MT; Catalán Ramos A; Parellada Esquius N
    Aten Primaria; 1994 Dec; 14(10):1128-34. PubMed ID: 7849214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Experience of the British health care system reform after the 1989 White Book and its possible application for the rational use of pharmaceuticals in Spain].
    Alfonso Galán MT
    Rev Sanid Hig Publica (Madr); 1994; 68(3):355-9. PubMed ID: 7716425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The utilization of anti-infective agents in primary care in La Rioja].
    Goldaracena Tanco M; Hernández Dettoma JL; Obaldía Alaãna C; Ortega Martínez J; Siles Gutiérrez M
    Aten Primaria; 1998 Nov; 22(9):574-9. PubMed ID: 9887579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prescription charges in rural practices: difficulties encountered in prescribing.
    Bills J
    N Z Med J; 1989 Apr; 102(866):202. PubMed ID: 2710459
    [No Abstract]   [Full Text] [Related]  

  • 46. Society offers second drug cost chart.
    Pa Med; 1994 Apr; 97(4):17. PubMed ID: 8008382
    [No Abstract]   [Full Text] [Related]  

  • 47. [Comparison of two models of prescription quality indicators in primary care].
    Gómez-Castro MJ; Arcos P; Rubiera G; Rigueira AI
    Gac Sanit; 2003; 17(5):375-83. PubMed ID: 14599420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Delegated prescription by specialists in primary care].
    Arroyo MP; Cano E; Ansorena R; Celay J; Cortés F; Estremera V
    Aten Primaria; 1995 Nov; 16(9):538-44. PubMed ID: 8562820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evolution of pharmaceutical provision in the National Health System (1984-1994)].
    Crespo Sánchez-Eznarriaga B; Guerra Aguirre FJ
    Aten Primaria; 1995 Nov; 16(9):546-50. PubMed ID: 8562821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost effective shopping for prescription drugs.
    Duvall LA; Campbell TA
    J S C Med Assoc; 1988 Feb; 84(2):78-81. PubMed ID: 3162287
    [No Abstract]   [Full Text] [Related]  

  • 51. [Should we assess the cost of a drug before prescribing it?].
    Giner Valero M; Feliu Sagalá M; López Martínez A; Gracia Romero L
    Aten Primaria; 1996 Feb; 17(3):233-4. PubMed ID: 8664439
    [No Abstract]   [Full Text] [Related]  

  • 52. Rational prescribing of antibacterials in hospitalised children.
    Hoppe JE
    Pharmacoeconomics; 1996 Dec; 10(6):575-93. PubMed ID: 10164059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Factors determining costs of drug prescriptions in primary health care].
    Cabedo García VR; Poveda Andrés JL; Peiró Moreno S; Nacher Fernández A; Goterris Pinto MA
    Aten Primaria; 1995 Oct; 16(7):407-8, 410-2, 414-6. PubMed ID: 7495949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of the utilization of real-time prescription benefits for patient cost savings within an outpatient setting.
    Reise R; Ndai AM; Dewar MA; Schentrup AM; Yang J; Vouri SM
    Explor Res Clin Soc Pharm; 2024 Jun; 14():100460. PubMed ID: 38974055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Potential impact of primary health care reform on drug prescription in Spain: the Ciutat Badia experience].
    Rey ME; Villalbí JR
    Med Clin (Barc); 1987 Jun; 89(4):141-3. PubMed ID: 3626659
    [No Abstract]   [Full Text] [Related]  

  • 56. Cost-related information to be provided by computerised drug-prescription systems to promote cost-effective prescribing.
    Milstein C; Venot A
    Pharmacoeconomics; 1997 Aug; 12(2 Pt 1):130-9. PubMed ID: 10169666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Generic drugs in Spain: first stage].
    Siles Gutiérrez M; Goldaracena Tanco M
    Aten Primaria; 2000; 26(3):162-8. PubMed ID: 10996949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of selective financing of drugs on pharmaceutical expenditure control in the province of Valladolid, Spain.
    de Marino MA; Marqués JM; Velasco A
    Pharmacoeconomics; 1996 Sep; 10(3):269-80. PubMed ID: 10163574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Induced prescription: excuse or reality?].
    García Vicente JA; Cordón Granados F
    Aten Primaria; 1998 Dec; 22(10):619-21. PubMed ID: 9931555
    [No Abstract]   [Full Text] [Related]  

  • 60. [Is there awareness of pharmaceutical expenditure in the reformed primary care system?].
    Mengíbar Torres F
    Aten Primaria; 2001 Apr; 27(6):408-11. PubMed ID: 11334578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.